Comprehensive Transplant Institute, University of Alabama at Birmingham, Birmingham, AL.
Department of Surgery, Division of Transplantation, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL.
Ann Surg. 2024 Sep 1;280(3):374-382. doi: 10.1097/SLA.0000000000006380. Epub 2024 Jun 6.
We sought to determine if genetically modified porcine kidneys used for xenotransplantation had sufficient tissue integrity to support long-term function in a human recipient.
Kidney transplantation remains the best available treatment for patients with end-stage kidney disease. However, a shortage of available donor human kidneys prevents many patients from achieving the benefits of transplantation. Xenotransplantation is a potential solution to this shortage. Recent pre-clinical human studies have demonstrated kidneys from genetically modified pig donors can be transplanted without hyperacute rejection and are capable of providing creatinine and other solute clearance. It is unknown whether the porcine kidneys would tolerate the relatively higher resting blood pressure in an adult human recipient compared with the pig donor or non-human primate (NHP) recipients used in translational studies. Furthermore, previous experience in NHPs raised concerns about the tissue integrity of the porcine ureter and post-xenotransplant growth of the porcine kidney.
Kidneys recovered from porcine donors with 10 gene edits were transplanted into decedent brain-dead recipients who were not eligible for organ donation. Decedents underwent bilateral native nephrectomy before transplant and were followed for 3 to 7 days. Standard induction and maintenance immunosuppression was used as previously reported. Vital signs, including blood pressure, were recorded frequently. Kidney xenografts were assessed daily, serially biopsied, and were measured at implantation and study completion.
Three decedents underwent successful xenotransplantation. Subcapsular hematomas developed, requiring incision of the xenograft capsules to prevent Page kidney. Blood pressures were maintained in a physiologic range for adult humans (median arterial pressures (MAP) 108.5 mm Hg (Interquartile Range (IQR): 97-114 mm Hg), 74 mm Hg (IQR: 71-78 mm Hg), and 95 mm Hg (IQR: 88-99 mm Hg, respectively) and no bleeding complications or aneurysm formation was observed. Serial biopsies were taken from the xenografts without apparent loss of tissue integrity despite the lack of a capsule. Ureteroneocystotomies remained intact without evidence of urine leak. Xenograft growth was observed, but plateaued, in 1 decedent with increased volume of the left and right xenografts by 25% and 26%, respectively, and in the context of human growth hormone levels consistently less <0.1 ng/ml and insulin-like growth factor 1 levels ranging from 34-50 ng/ml.
The findings of this study suggest kidneys from 10-gene edited porcine donors have sufficient tissue integrity to tolerate xenotransplantation into a living human recipient. There was no evidence of anastomotic complications, and the xenografts tolerated needle biopsy without issue. Xenograft growth occurred but plateaued by the study end; further observation and investigation will be required to confirm this finding and elucidate underlying mechanisms.
我们旨在确定用于异种移植的基因修饰猪肾脏是否具有足够的组织完整性,以支持人类受者的长期功能。
肾移植仍然是终末期肾病患者的最佳治疗方法。然而,可用的人类供体肾脏短缺,使许多患者无法受益于移植。异种移植是解决这一短缺的潜在方法。最近的临床前人体研究表明,来自基因修饰猪供体的肾脏可以在没有超急性排斥反应的情况下移植,并能够提供肌酐和其他溶质清除率。目前尚不清楚与用于转化研究的猪供体或非人类灵长类动物(NHP)受者相比,猪肾脏是否能耐受成人受者相对较高的静息血压。此外,以前在 NHP 中的经验引起了对猪输尿管组织完整性的担忧和异种移植后猪肾脏的生长。
从经过 10 种基因编辑的猪供体中回收的肾脏被移植到不符合器官捐献条件的脑死亡受者中。在移植前,死者接受双侧原生肾切除术,并随访 3 至 7 天。使用了以前报道的标准诱导和维持免疫抑制。频繁记录生命体征,包括血压。每天评估异种移植物,连续进行活检,并在植入和研究完成时进行测量。
三名死者成功进行了异种移植。发生了包膜下血肿,需要切开异种移植物包膜以防止 Page 肾。成人的血压维持在生理范围内(中位动脉压(MAP)为 108.5mmHg(IQR:97-114mmHg),74mmHg(IQR:71-78mmHg)和 95mmHg(IQR:88-99mmHg),未观察到出血并发症或动脉瘤形成。尽管没有包膜,从异种移植物中连续进行活检也没有明显的组织完整性丧失。输尿管-尿囊吻合术保持完整,无尿液泄漏的证据。在 1 名死者中观察到异种移植物生长,但在研究结束时趋于稳定,左、右异种移植物的体积分别增加了 25%和 26%,而人类生长激素水平持续<0.1ng/ml,胰岛素样生长因子 1 水平在 34-50ng/ml 之间。
本研究结果表明,来自 10 种基因编辑猪供体的肾脏具有足够的组织完整性,可耐受异种移植到活体人类受者体内。没有吻合口并发症的证据,异种移植物耐受活检而没有问题。异种移植物生长发生,但在研究结束时趋于稳定;需要进一步观察和研究来证实这一发现并阐明潜在的机制。